← Leaderboards
Geoffrey C Gurtner
New York University School Of Medicine
$18,025,276
Attributed
$24,008,842
Total exposure
11
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$24,008,842 · 11
By mechanism
R01$18,301,118 · 6
U01$4,342,001 · 1
R21$575,934 · 1
R56$500,000 · 1
T35$211,289 · 1
R03$78,500 · 1
Top collaborators
- Michael T Longaker9 shared
- Chandan K Sen6 shared
- Wei Zhou6 shared
- Michael A Brownlee5 shared
- James Kuang-Jan Liao1 shared
- Marlys Hearst Witte1 shared
Others in their field
Top investigators on “Wound Healing”
- Elaine Fuchs · University Of Chicago$22,627,131
- Luisa A Dipietro · University Of Illinois At Chicago$15,645,573
- Donald R Gerecke · Rutgers The St Univ Of Nj New Brunswick$15,176,497
- Anna Huttenlocher · University Of Wisconsin-Madison$15,052,155
- Wendell A Lim · University Of California, San Francisco$14,630,990
- Wendy L Havran · Scripps Research Institute$14,490,138
Research focus
Wound HealingTissuesCellsPreventFundingDiabetic PatientBlood VesselsHealingWoundStem CellsLaboratoriesAffectDefectMolecularResponseGrowthNeovascularizationClinical ResearchImpairmentPathway InteractionsUnited StatesDiabetes MellitusIn VitroBone Marrow
Grant awards (68)
The University of Arizona Wound Care Center Clinical Research Unit$746,601
U01 · FY2025 · DK · contact PI
TARGETING HIF-1α DYSFUNCTION TO TREAT PRESSURE ULCERS IN THE AGED$554,284
R01 · FY2025 · AG · contact PI
Correcting the Cellular Ecology of Diabetic Complications$383,750
R01 · FY2025 · DK · contact PI
Short-Term Institutional Research Training Grant$211,289
T35 · FY2025 · HL
The University of Arizona Wound Care Center Clinical Research Unit$76,149
U01 · FY2025 · DK · contact PI
The University of Arizona Wound Care Center Clinical Research Unit$733,314
U01 · FY2024 · DK · contact PI
Diabetic Foot Ulcer Biofilm Infection and Recurrence$567,468
R01 · FY2024 · DK
Correcting the Cellular Ecology of Diabetic Complications$368,400
R01 · FY2024 · DK · contact PI
TARGETING HIF-1α DYSFUNCTION TO TREAT PRESSURE ULCERS IN THE AGED$344,520
R01 · FY2024 · AG · contact PI
The University of Arizona Wound Care Center Clinical Research Unit$31,679
U01 · FY2024 · DK · contact PI
Diabetic Foot Ulcer Biofilm Infection and Recurrence$607,114
R01 · FY2023 · DK
The University of Arizona Wound Care Center Clinical Research Unit$536,628
U01 · FY2023 · DK · contact PI
Correcting the Cellular Ecology of Diabetic Complications$383,750
R01 · FY2023 · DK · contact PI
TARGETING HIF-1α DYSFUNCTION TO TREAT PRESSURE ULCERS IN THE AGED$331,245
R01 · FY2023 · AG · contact PI
The University of Arizona Wound Care Center Clinical Research Unit$200,000
U01 · FY2023 · DK · contact PI
Diabetic Foot Ulcer Biofilm Infection and Recurrence$642,197
R01 · FY2022 · DK
Correcting the Cellular Ecology of Diabetic Complications$383,750
R01 · FY2022 · DK · contact PI
TARGETING HIF-1α DYSFUNCTION TO TREAT PRESSURE ULCERS IN THE AGED$325,690
R01 · FY2022 · AG · contact PI
Stanford Advanced Wound Care Center Clinical Research Unit$210,295
U01 · FY2022 · DK · contact PI
Diabetic Foot Ulcer Biofilm Infection and Recurrence$651,483
R01 · FY2021 · DK
Stanford Advanced Wound Care Center Clinical Research Unit$431,750
U01 · FY2021 · DK · contact PI
Diabetic Foot Ulcer Biofilm Infection and Recurrence$377,021
R01 · FY2021 · DK
Stanford Advanced Wound Care Center Clinical Research Unit$40,136
U01 · FY2021 · DK · contact PI
Diabetic Foot Ulcer Biofilm Infection and Recurrence$663,367
R01 · FY2020 · DK
Stanford Advanced Wound Care Center Clinical Research Unit$431,750
U01 · FY2020 · DK · contact PI
Stanford Advanced Wound Care Center Clinical Research Unit$40,199
U01 · FY2020 · DK · contact PI
Stanford Advanced Wound Care Center Clinical Research Unit$431,750
U01 · FY2019 · DK · contact PI
Stanford Advanced Wound Care Center Clinical Research Unit$431,750
U01 · FY2018 · DK · contact PI
Reversal of Progenitor Cell Deficits in Diabetes$362,366
R01 · FY2018 · DK · contact PI
Reversal of Progenitor Cell Deficits in Diabetes$362,366
R01 · FY2017 · DK · contact PI
Osteogenic Enrichment of Adipose Derived Stromal Cells$395,114
R01 · FY2016 · DE
Reversal of Progenitor Cell Deficits in Diabetes$362,366
R01 · FY2016 · DK · contact PI
Osteogenic Enrichment of Adipose Derived Stromal Cells$395,013
R01 · FY2015 · DE
Reversal of Progenitor Cell Deficits in Diabetes$362,366
R01 · FY2015 · DK · contact PI
Targeting HIF-1 alpha Dysfunction in Complications of Aging$315,120
R01 · FY2015 · AG · contact PI
Osteogenic Enrichment of Adipose Derived Stromal Cells$394,916
R01 · FY2014 · DE
Targeting HIF-1 alpha Dysfunction in Complications of Aging$324,811
R01 · FY2014 · AG · contact PI
Progenitor Cell Dysfunction and Impaired Neovascularization in Diabetes$450,529
R01 · FY2013 · DK · contact PI
Osteogenic Enrichment of Adipose Derived Stromal Cells$379,029
R01 · FY2013 · DE
Inside-Out Tissue Engineering for Organ Fabrication$326,817
R01 · FY2013 · EB · contact PI
Targeting HIF-1 alpha Dysfunction in Complications of Aging$306,898
R01 · FY2013 · AG · contact PI
Progenitor Cell Dysfunction and Impaired Neovascularization in Diabetes$469,196
R01 · FY2012 · DK · contact PI
Osteogenic Enrichment of Adipose Derived Stromal Cells$394,649
R01 · FY2012 · DE
Inside-Out Tissue Engineering for Organ Fabrication$346,551
R01 · FY2012 · EB · contact PI
Targeting HIF-1 alpha Dysfunction in Complications of Aging$324,712
R01 · FY2012 · AG · contact PI
Progenitor Cell Dysfunction and Impaired Neovascularization in Diabetes$471,152
R01 · FY2011 · DK · contact PI
Inside-Out Tissue Engineering for Organ Fabrication$346,530
R01 · FY2011 · EB · contact PI
Targeting HIF-1 alpha Dysfunction in Complications of Aging$324,665
R01 · FY2011 · AG · contact PI
Transdermal Delivery of Deferoxamine to Prevent and Treat Diabetic Wounds$78,500
R03 · FY2011 · DK · contact PI
Progenitor Cell Dysfunction and Impaired Neovascularization in Diabetes$622,398
R01 · FY2010 · DK · contact PI
Inside-Out Tissue Engineering for Organ Fabrication$360,498
R01 · FY2010 · EB · contact PI
Progenitor Cell Dysfunction and Impaired Neovascularization in Diabetes$500,000
R56 · FY2009 · DK · contact PI
Impaired Stem Cell Trafficking in Complications of Aging$453,120
R01 · FY2008 · AG · contact PI
Progenitor Cell Dysfunction and Impaired Vasculogenesis in Diabetic Complications$333,960
R01 · FY2008 · DK · contact PI
Impaired Stem Cell Trafficking in Complications of Aging$117,372
R01 · FY2008 · AG · contact PI
Progenitor Cell Dysfunction and Impaired Vasculogenesis in Diabetic Complications$340,754
R01 · FY2007 · DK · contact PI
Impaired Stem Cell Trafficking in Complications of Aging$303,835
R01 · FY2007 · AG · contact PI
Progenitor Cell Dysfunction and Impaired Vasculogenesis$350,909
R01 · FY2006 · DK · contact PI
Impaired Stem Cell Trafficking in Complications of Aging$312,593
R01 · FY2006 · AG · contact PI
Impaired Stem Cell Trafficking in Complications of Aging$407,164
R01 · FY2005 · AG
Progenitor Cell Dysfunction and Impaired Vasculogenesis$359,333
R01 · FY2005 · DK
Impaired Stem Cell Trafficking in Complications of Aging$15,774
R01 · FY2005 · AG
Impaired Stem Cell Trafficking in Complications of Aging$324,203
R01 · FY2004 · AG
Explanted Vascular Beds for Complex Tissue Engineering$216,309
R21 · FY2004 · EB
Explanted Vascular Beds for Complex Tissue Engineering$72,670
R21 · FY2004 · EB
Explanted Vascular Beds for Complex Tissue Engineering$46,198
R21 · FY2004 · EB
Explanted Vascular Beds for Complex Tissue Engineering$15,464
R21 · FY2004 · EB
Explanted Vascular Beds for Complex Tissue Engineering$225,293
R21 · FY2003 · EB